The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug Discovery Assays Market Research Report 2024

Global Drug Discovery Assays Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1902865

No of Pages : 107

Ask Your Query
Synopsis
The global Drug Discovery Assays market was valued at US$ 7150 million in 2023 and is anticipated to reach US$ 12900 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The Drug Discovery Assays market is a fundamental and dynamic sector within the pharmaceutical and biotechnology industry, offering a wide array of techniques and tools to identify and validate potential drug candidates. These assays encompass various approaches, such as high-throughput screening, cell-based assays, biochemical assays, and target-based assays, which are vital in the drug discovery process, from target identification to lead optimization. They are known for their ability to provide critical insights into the pharmacological and toxicological properties of compounds, facilitating the development of novel drugs and therapies. The market is characterized by ongoing technological advancements, automation, and the integration of artificial intelligence and machine learning to enhance the efficiency and accuracy of drug discovery processes. Leading providers in the life sciences and biotechnology sector, including PerkinElmer, Thermo Fisher Scientific, and Promega Corporation, focus on delivering innovative assay technologies and platforms that cater to the evolving needs of pharmaceutical companies and research institutions. As the pharmaceutical industry continues to advance toward personalized medicine, precision therapeutics, and the development of treatments for various diseases, the Drug Discovery Assays market is poised for sustained growth, offering indispensable tools for accelerating drug discovery, improving drug safety, and enhancing the efficiency of bringing new medications to market.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Assays.
Report Scope
The Drug Discovery Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Danaher
Becton Dickinson
GE Healthcare
Merck
Lonza
PerkinElmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technologies
Cisbio
Cell Biolabs, Inc.
Promega
Pfizer
GSK
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Segment by Type
Consumables
Instruments
Services
Software
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Drug Discovery Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Government Institutions
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Assays Market Perspective (2019-2030)
2.2 Drug Discovery Assays Growth Trends by Region
2.2.1 Global Drug Discovery Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Assays Historic Market Size by Region (2019-2024)
2.2.3 Drug Discovery Assays Forecasted Market Size by Region (2025-2030)
2.3 Drug Discovery Assays Market Dynamics
2.3.1 Drug Discovery Assays Industry Trends
2.3.2 Drug Discovery Assays Market Drivers
2.3.3 Drug Discovery Assays Market Challenges
2.3.4 Drug Discovery Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Assays Players by Revenue
3.1.1 Global Top Drug Discovery Assays Players by Revenue (2019-2024)
3.1.2 Global Drug Discovery Assays Revenue Market Share by Players (2019-2024)
3.2 Global Drug Discovery Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Assays Revenue
3.4 Global Drug Discovery Assays Market Concentration Ratio
3.4.1 Global Drug Discovery Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Assays Revenue in 2023
3.5 Drug Discovery Assays Key Players Head office and Area Served
3.6 Key Players Drug Discovery Assays Product Solution and Service
3.7 Date of Enter into Drug Discovery Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Assays Breakdown Data by Type
4.1 Global Drug Discovery Assays Historic Market Size by Type (2019-2024)
4.2 Global Drug Discovery Assays Forecasted Market Size by Type (2025-2030)
5 Drug Discovery Assays Breakdown Data by Application
5.1 Global Drug Discovery Assays Historic Market Size by Application (2019-2024)
5.2 Global Drug Discovery Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Assays Market Size (2019-2030)
6.2 North America Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Discovery Assays Market Size by Country (2019-2024)
6.4 North America Drug Discovery Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Assays Market Size (2019-2030)
7.2 Europe Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Discovery Assays Market Size by Country (2019-2024)
7.4 Europe Drug Discovery Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Assays Market Size (2019-2030)
8.2 Asia-Pacific Drug Discovery Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Discovery Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Discovery Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Assays Market Size (2019-2030)
9.2 Latin America Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Discovery Assays Market Size by Country (2019-2024)
9.4 Latin America Drug Discovery Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Assays Market Size (2019-2030)
10.2 Middle East & Africa Drug Discovery Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Discovery Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Discovery Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Drug Discovery Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Drug Discovery Assays Introduction
11.2.4 Danaher Revenue in Drug Discovery Assays Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Drug Discovery Assays Introduction
11.3.4 Becton Dickinson Revenue in Drug Discovery Assays Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Drug Discovery Assays Introduction
11.4.4 GE Healthcare Revenue in Drug Discovery Assays Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Drug Discovery Assays Introduction
11.5.4 Merck Revenue in Drug Discovery Assays Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Drug Discovery Assays Introduction
11.6.4 Lonza Revenue in Drug Discovery Assays Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Detail
11.7.2 PerkinElmer, Inc. Business Overview
11.7.3 PerkinElmer, Inc. Drug Discovery Assays Introduction
11.7.4 PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.7.5 PerkinElmer, Inc. Recent Development
11.8 Charles River Laboratories, Inc.
11.8.1 Charles River Laboratories, Inc. Company Detail
11.8.2 Charles River Laboratories, Inc. Business Overview
11.8.3 Charles River Laboratories, Inc. Drug Discovery Assays Introduction
11.8.4 Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.8.5 Charles River Laboratories, Inc. Recent Development
11.9 Cell Signaling Technologies
11.9.1 Cell Signaling Technologies Company Detail
11.9.2 Cell Signaling Technologies Business Overview
11.9.3 Cell Signaling Technologies Drug Discovery Assays Introduction
11.9.4 Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2019-2024)
11.9.5 Cell Signaling Technologies Recent Development
11.10 Cisbio
11.10.1 Cisbio Company Detail
11.10.2 Cisbio Business Overview
11.10.3 Cisbio Drug Discovery Assays Introduction
11.10.4 Cisbio Revenue in Drug Discovery Assays Business (2019-2024)
11.10.5 Cisbio Recent Development
11.11 Cell Biolabs, Inc.
11.11.1 Cell Biolabs, Inc. Company Detail
11.11.2 Cell Biolabs, Inc. Business Overview
11.11.3 Cell Biolabs, Inc. Drug Discovery Assays Introduction
11.11.4 Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2019-2024)
11.11.5 Cell Biolabs, Inc. Recent Development
11.12 Promega
11.12.1 Promega Company Detail
11.12.2 Promega Business Overview
11.12.3 Promega Drug Discovery Assays Introduction
11.12.4 Promega Revenue in Drug Discovery Assays Business (2019-2024)
11.12.5 Promega Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Drug Discovery Assays Introduction
11.13.4 Pfizer Revenue in Drug Discovery Assays Business (2019-2024)
11.13.5 Pfizer Recent Development
11.14 GSK
11.14.1 GSK Company Detail
11.14.2 GSK Business Overview
11.14.3 GSK Drug Discovery Assays Introduction
11.14.4 GSK Revenue in Drug Discovery Assays Business (2019-2024)
11.14.5 GSK Recent Development
11.15 Agilent
11.15.1 Agilent Company Detail
11.15.2 Agilent Business Overview
11.15.3 Agilent Drug Discovery Assays Introduction
11.15.4 Agilent Revenue in Drug Discovery Assays Business (2019-2024)
11.15.5 Agilent Recent Development
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Company Detail
11.16.2 Eli Lilly and Company Business Overview
11.16.3 Eli Lilly and Company Drug Discovery Assays Introduction
11.16.4 Eli Lilly and Company Revenue in Drug Discovery Assays Business (2019-2024)
11.16.5 Eli Lilly and Company Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Drug Discovery Assays Introduction
11.17.4 Roche Revenue in Drug Discovery Assays Business (2019-2024)
11.17.5 Roche Recent Development
11.18 Bayer
11.18.1 Bayer Company Detail
11.18.2 Bayer Business Overview
11.18.3 Bayer Drug Discovery Assays Introduction
11.18.4 Bayer Revenue in Drug Discovery Assays Business (2019-2024)
11.18.5 Bayer Recent Development
11.19 Abbott
11.19.1 Abbott Company Detail
11.19.2 Abbott Business Overview
11.19.3 Abbott Drug Discovery Assays Introduction
11.19.4 Abbott Revenue in Drug Discovery Assays Business (2019-2024)
11.19.5 Abbott Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Detail
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Drug Discovery Assays Introduction
11.20.4 AstraZeneca Revenue in Drug Discovery Assays Business (2019-2024)
11.20.5 AstraZeneca Recent Development
11.21 Shimadzu
11.21.1 Shimadzu Company Detail
11.21.2 Shimadzu Business Overview
11.21.3 Shimadzu Drug Discovery Assays Introduction
11.21.4 Shimadzu Revenue in Drug Discovery Assays Business (2019-2024)
11.21.5 Shimadzu Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock